Scimago Journal & Country Rank
menu
| Title | Type |  SJR |
H index | Total Docs. (2015) | Total Docs. (3years) | Total Refs. (2015) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2015) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 51 | Trials | journal | 1.235 Q1 | 98 | 594 | 1197 | 24419 | 2965 | 1176 | 2.23 | 41.11 |  |
| 52 | CPT: Pharmacometrics and Systems Pharmacology | journal | 1.213 Q1 | 55 | 80 | 141 | 2796 | 511 | 133 | 3.46 | 34.95 |  |
| 53 | Recent Patents on Anti-Cancer Drug Discovery | journal | 1.211 Q1 | 52 | 27 | 70 | 2347 | 254 | 66 | 3.80 | 86.93 |  |
| 54 | Current Treatment Options in Oncology | journal | 1.202 Q1 | 66 | 58 | 143 | 3971 | 475 | 143 | 2.78 | 68.47 | |
| 55 | Pharmaceutical Statistics | journal | 1.180 Q1 | 46 | 57 | 160 | 1388 | 177 | 149 | 1.20 | 24.35 | |
| 56 | Biologics: Targets and Therapy | journal | 1.172 Q1 | 47 | 16 | 95 | 839 | 377 | 94 | 4.90 | 52.44 |  |
| 57 | Journal of Supportive Oncology | journal | 1.157 Q1 | 65 | 0 | 69 | 0 | 176 | 53 | 2.48 | 0.00 | |
| 58 | Pharmaceutical Research | journal | 1.155 Q1 | 229 | 308 | 822 | 13837 | 3340 | 811 | 3.90 | 44.93 | |
| 59 | Journal of Clinical Psychopharmacology | journal | 1.154 Q1 | 130 | 185 | 579 | 4582 | 1258 | 311 | 1.88 | 24.77 | |
| 60 | European Journal of Clinical Pharmacology | journal | 1.146 Q1 | 123 | 182 | 664 | 6280 | 2036 | 583 | 2.97 | 34.51 |  |
| 61 | OncoTargets and Therapy | journal | 1.140 Q1 | 86 | 444 | 497 | 15575 | 1701 | 496 | 3.51 | 35.08 | |
| 62 | Acta Pharmacologica Sinica | journal | 1.136 Q1 | 117 | 152 | 548 | 7530 | 1739 | 538 | 3.12 | 49.54 | |
| 63 | Journal of Cardiovascular Pharmacology and Therapeutics | journal | 1.110 Q1 | 57 | 60 | 177 | 2823 | 515 | 172 | 3.10 | 47.05 | |
| 64 | Antimicrobial Resistance and Infection Control | journal | 1.093 Q1 | 66 | 56 | 101 | 1772 | 295 | 89 | 2.92 | 31.64 | |
| 65 | Journal of Aerosol Medicine and Pulmonary Drug Delivery | journal | 1.092 Q1 | 81 | 49 | 149 | 1700 | 453 | 144 | 2.83 | 34.69 | |
| 66 | Expert Opinion on Drug Safety | journal | 1.058 Q1 | 90 | 164 | 341 | 12223 | 1142 | 332 | 3.37 | 74.53 | |
| 67 | Clinical Therapeutics | journal | 1.053 Q1 | 150 | 270 | 644 | 9992 | 1938 | 573 | 2.83 | 37.01 | |
| 68 | Expert Opinion on Emerging Drugs | journal | 1.051 Q2 | 54 | 50 | 125 | 4861 | 374 | 122 | 2.58 | 97.22 | |
| 69 | International Clinical Psychopharmacology | journal | 1.048 Q2 | 98 | 50 | 136 | 1797 | 492 | 135 | 3.14 | 35.94 | |
| 70 | Expert Review of Neurotherapeutics | journal | 1.037 Q2 | 98 | 110 | 448 | 8907 | 1298 | 413 | 2.60 | 80.97 | |
| 71 | Inflammopharmacology | journal | 1.031 Q2 | 68 | 32 | 113 | 1955 | 365 | 105 | 2.75 | 61.09 |  |
| 72 | HIV Clinical Trials | journal | 1.027 Q2 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | |
| 73 | Pulmonary Pharmacology and Therapeutics | journal | 1.015 Q2 | 81 | 110 | 260 | 5529 | 765 | 236 | 3.08 | 50.26 | |
| 74 | Journal of Clinical Pharmacology | journal | 0.993 Q2 | 130 | 186 | 550 | 5879 | 1511 | 515 | 2.83 | 31.61 | |
| 75 | Pharmacotherapy | journal | 0.993 Q2 | 126 | 152 | 478 | 5245 | 1432 | 440 | 2.91 | 34.51 | |
| 76 | PPAR Research | journal | 0.992 Q2 | 59 | 23 | 151 | 1800 | 379 | 144 | 2.94 | 78.26 | |
| 77 | Human Psychopharmacology | journal | 0.974 Q2 | 86 | 52 | 232 | 2845 | 657 | 227 | 3.03 | 54.71 | |
| 78 | Cardiology | journal | 0.937 Q2 | 72 | 141 | 430 | 3370 | 715 | 300 | 1.47 | 23.90 | |
| 79 | Journal of Child and Adolescent Psychopharmacology | journal | 0.932 Q2 | 92 | 135 | 299 | 4065 | 588 | 209 | 1.75 | 30.11 | |
| 80 | American Journal of Cardiovascular Drugs | journal | 0.920 Q2 | 60 | 44 | 128 | 2273 | 322 | 121 | 2.49 | 51.66 | |
| 81 | Expert Opinion on Pharmacotherapy | journal | 0.907 Q2 | 93 | 251 | 734 | 17110 | 2183 | 705 | 3.15 | 68.17 | |
| 82 | Annals of Pharmacotherapy | journal | 0.901 Q2 | 122 | 176 | 747 | 5475 | 1864 | 661 | 2.46 | 31.11 | |
| 83 | Vascular Health and Risk Management | journal | 0.900 Q2 | 82 | 62 | 224 | 3538 | 629 | 218 | 2.77 | 57.06 | |
| 84 | BioDrugs | journal | 0.894 Q2 | 79 | 35 | 146 | 2111 | 483 | 141 | 3.39 | 60.31 | |
| 85 | Journal of Addiction Medicine | journal | 0.882 Q2 | 58 | 84 | 200 | 2099 | 418 | 190 | 2.20 | 24.99 | |
| 86 | Vaccines | journal | 0.882 Q2 | 85 | 51 | 44 | 4651 | 82 | 42 | 1.86 | 91.20 | |
| 87 | Clinical Psychopharmacology and Neuroscience | journal | 0.864 Q2 | 42 | 52 | 92 | 2028 | 202 | 87 | 1.87 | 39.00 |  |
| 88 | Paediatric Drugs | journal | 0.855 Q2 | 70 | 50 | 142 | 3028 | 340 | 136 | 2.56 | 60.56 | |
| 89 | BMC pharmacology & toxicology | journal | 0.853 Q2 | 43 | 41 | 160 | 1456 | 393 | 154 | 2.57 | 35.51 | |
| 90 | AIDS Research and Therapy | journal | 0.851 Q2 | 49 | 44 | 109 | 1512 | 210 | 108 | 1.76 | 34.36 | |
| 91 | Drug Target Insights | journal | 0.845 Q2 | 16 | 5 | 17 | 225 | 52 | 17 | 3.23 | 45.00 |  |
| 92 | Journal of Biopharmaceutical Statistics | journal | 0.844 Q2 | 56 | 82 | 258 | 1905 | 208 | 243 | 0.80 | 23.23 | |
| 93 | Advances in Therapy | journal | 0.843 Q2 | 83 | 90 | 241 | 3623 | 757 | 236 | 2.80 | 40.26 | |
| 94 | Expert Review of Pharmacoeconomics and Outcomes Research | journal | 0.818 Q2 | 61 | 103 | 253 | 4429 | 519 | 243 | 1.81 | 43.00 | |
| 95 | Expert Review of Clinical Pharmacology | journal | 0.817 Q2 | 60 | 58 | 249 | 4113 | 574 | 215 | 2.41 | 70.91 | |
| 96 | BMC Pharmacology | journal | 0.805 Q2 | 48 | 0 | 8 | 0 | 32 | 8 | 0.00 | 0.00 | |
| 97 | Drug Metabolism and Pharmacokinetics | journal | 0.805 Q2 | 75 | 65 | 237 | 2463 | 584 | 218 | 1.89 | 37.89 |  |
| 98 | Expert Review of Anticancer Therapy | journal | 0.795 Q2 | 85 | 127 | 473 | 8904 | 1016 | 449 | 2.07 | 70.11 | |
| 99 | Clinical Neuropharmacology | journal | 0.788 Q2 | 85 | 57 | 169 | 1544 | 394 | 162 | 2.24 | 27.09 | |
| 100 | Anti-Cancer Drugs | journal | 0.783 Q2 | 102 | 123 | 409 | 4015 | 934 | 402 | 2.42 | 32.64 | |
Powered by:
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®
Download data